Could an experimental drug trio fight difficult-to-treat pancreatic cancer? Experiments in mouse models show promise. Image credit: adamkaz/Getty Images
Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer, and it can be challenging to treat.
One struggle is tumor resistance to a group of medications called RAS(ON)…